The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam

被引：0
|
作者：
Peterson, Katherine L. [1 ]
Tompkins, Bradley J. [2 ]
Ahern, John W. [3 ]
Smith, Lindsay M. [1 ]
机构：
[1] Univ Vermont Med Ctr, Div Infect Dis, 111 Colchester Ave, Burlington, VT 05401 USA
[2] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA
[3] Univ Vermont Med Ctr, Dept Pharm, Burlington, VT USA
来源：
ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY | 2022年 / 2卷 / 01期
关键词：
INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; STEWARDSHIP; PROGRAM; AMERICA; GUIDELINES;
D O I：
10.1017/ash.2022.12
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Impact of a Best-Practice Advisory on Inpatient Use of Piperacillin-Tazobactam
    Peterson, Katherine
    Smith, Lindsay
    Ahern, John
    Tompkins, Bradley
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S406 - S407
  • [2] Appropriate prescribing of piperacillin-tazobactam in a teaching hospital
    Fanny, V.
    Sneyers, B.
    Yombi, J. -C.
    Jonckeere, S.
    Belkhir, L.
    Briquet, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 990 - 990
  • [3] Inappropriate prescribing of piperacillin-tazobactam in a Belgian Teaching Hospital
    Vaillant, Fanny
    Sneyers, Barbara
    Yombi, J-C
    Jonckeere, Sylvie
    Belkhir, Leila
    Briquet, Caroline
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (05) : 793 - 793
  • [4] Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations
    Liu, Q
    Rand, K
    Derendorf, H
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (05) : 494 - 497
  • [5] Piperacillin-tazobactam desensitisation
    Sanchez Ramos, I
    Puente Crespo, Y.
    Daza Munoz, J.
    Guardia Martinez, P.
    Conde Hernandez, J.
    ALLERGY, 2008, 63 : 242 - 242
  • [6] Allergy to piperacillin-tazobactam
    Burches-Feliciano, M.
    Restrepo-Tinoco, L.
    Delgado-Prada, A.
    Compadre-Hernandez, J.
    Burches, E.
    ALLERGY, 2021, 76 : 292 - 293
  • [7] Reevaluating Piperacillin-Tazobactam Mortality
    Chao, Chia-Ter
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1268 - 1268
  • [8] Pharmacokinetic evaluation of piperacillin-tazobactam
    Hayashi, Yoshiro
    Roberts, Jason A.
    Paterson, David L.
    Lipman, Jeffrey
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (08) : 1017 - 1031
  • [9] Dress induced by piperacillin-tazobactam in a child
    Gonzalez Diaz, Carlos
    Gonzalez Hermosa, Andres
    Garcia-Lirio, Eduardo
    Martinez-Aranguren, Ruben
    Gamboa Setien, Pedro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (04): : 615 - 617
  • [10] Drug Fever Caused by Piperacillin-Tazobactam
    Linares, T.
    Fernandez, A.
    Soto, M. T.
    Escudero, E.
    Gacias, L.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2011, 21 (03) : 250 - 251
12345